Baird Initiates Coverage On CVS Health with Neutral Rating, Announces Price Target of $61
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Michael Ha has initiated coverage on CVS Health with a Neutral rating and set a price target of $61.
May 30, 2024 | 9:52 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Baird analyst Michael Ha has initiated coverage on CVS Health with a Neutral rating and set a price target of $61.
The Neutral rating suggests that the analyst does not expect significant upside or downside in the short term. The price target of $61 provides a specific valuation benchmark for investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100